Yanda International Hospital
Diabetes type 2 treatment cost in China typically involves metabolic surgery which runs from $14,500 to $24,500 or innovative stem cell for diabetes therapies costing $18,500 to $29,500. Total expenses depend heavily on the presence of complications, the level of the medical facility, and the specific treatment protocol. International patients often find significant savings of 30-50% compared to Western healthcare costs. Top destinations for advanced care include Beijing, Shanghai, and Tianjin.
Typical Diabetes Type 2 Treatment Costs in China
Bookimed Expert Insight: Patients seeking integrative care should consider Class A level III facilities like Yanda International Hospital. This center combines Western technology with traditional Chinese medicine under experts like Fan Yun Pin. Such an approach is best for managing complex endocrine disorders. The hospital maintains Joint Commission International (JCI) accreditation while serving over 2.5 million patients annually. This ensures high safety standards for international patients.
| China | Turkey | Austria | |
| Stem cell for diabetes | from $18,500 | from $12,000 | from $25,000 |
| Metabolic surgery | from $14,500 | from $4,140 | from $17,000 |
| Gastric band | from $8,800 | from $4,275 | from $14,000 |
| Bioidentical hormone replacement therapy (BHRT) | from $1,350 | from $800 | from $1,800 |
| Biliopancreatic diversion | from $14,500 | from $5,279 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Diabetes type 2 treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Diabetes type 2 treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Diabetes type 2 treatment journey.
Dr. Fan Yun Pin leads the National Society of Chinese Medicine and specializes in integrative Chinese and Western medicine approaches.
Dr Tian Jian Qing is Director of Endocrinology and a Senior Expert in Endocrine & Metabolic Therapeutics. He has over 20 years of clinical experience. He previously worked at Xinjiang Military Command General Hospital and at Renji Hospital, Shanghai Jiao Tong University.
He has published over 20 SCI and Chinese core journal papers. He is chief editor of four monographs and co-editor of four others. He has produced more than 1,000 health education materials. His clinical focus includes endocrine and metabolic disorders, dysglycemia, dyslipidemia, and hypertension. He also treats weight, thyroid, and bone diseases, menopausal syndrome, PCOS, and gestational diabetes and thyroid disorders.
He holds Standing Council and Committee roles in the Fujian Cross-Strait Medicine & Health Exchange Association and the Fujian Primary Health Association. He also serves in the Xiamen Medical Association and the Xiamen Medical Doctor Association. He is Deputy Chair of the Diabetes Branch of the Xiamen Medical Association.
Diabetes type 2 surgery in China is highly safe at JCI-accredited facilities following international protocols. Large-scale studies show a 100% survival rate for metabolic procedures in major centers. Success rates for glycemic control reach up to 90% depending on the specific surgical technique used.
Bookimed Expert Insight: While many focus on surgery, the most successful outcomes in China often come from `Class A Level III` institutions like Yanda International Hospital. These top-tier facilities serve 2,500,000 patients annually and combine Western surgical protocols with specialized endocrinology departments. This high volume leads to exceptional technical precision that smaller regional clinics cannot match.
Patient Consensus: Patients note that quality varies significantly between regions and strongly recommend sticking to top-tier hospitals in Beijing or Shanghai. Many emphasize that while surgical success is high, having a clear English-speaking coordinator is essential for managing post-operative recovery safely.
China offers metabolic surgeries and regenerative stem cell transplants to reverse type 2 diabetes. Standard procedures like Gastric Bypass and Sleeve Gastrectomy focus on hormonal rebalancing. Pioneering clinics also perform autologous stem cell-derived islet transplantations. These transplants aim for long-term insulin independence in chronic cases.
Bookimed Expert Insight: While many global centers focus solely on weight loss, Class A level III hospitals in China like Yanda International Hospital integrate traditional approaches with high-volume surgical expertise. Dr. Fan Yun Pin at Yanda specializes in complex metabolic syndrome cases. This combination of Western metabolic surgery and focused endocrine management supports a highly comprehensive recovery path for diabetic patients.
Patient Consensus: Patients report that while Roux-en-Y gastric bypass often provides faster results for insulin-dependent cases, choosing a JCI-accredited facility is vital for safety. Many emphasize the need to plan for a 4 to 6 week stay to complete all necessary follow-up tests.
Qualification for diabetes metabolic surgery in China requires a Type 2 diagnosis for 6+ months. Patients with a Body Mass Index (BMI) over 32.5 qualify most easily. Those with a BMI of 27.5 to 32.5 can qualify if medication fails to manage hyperglycemia. Preserved pancreatic function is essential for success.
Bookimed Expert Insight: Chinese Class A Level III hospitals like Yanda International Hospital offer a distinct advantage. They integrate western metabolic surgery with traditional Chinese medicine for endocrine disorders. This combined approach aims to stabilize metabolic syndrome more holistically than surgery alone. Dr. Fan Yun Pin at Yanda is a recognized leader in this integrative field.
Patient Consensus: Patients note that proving a 15-year or shorter history of diabetes significantly improves chances of approval. They emphasize that bringing complete medication records is the most critical step for international coordination.
Diabetes surgery in China achieves initial remission rates between 70% and 90% for type 2 patients. Long-term success focuses on maintaining blood sugar levels without medication for five years or more. Results depend on preoperative beta-cell function and a disease duration of under five years.
Bookimed Expert Insight: China's top-tier Class A level III facilities like Yanda International Hospital manage massive patient volumes. This scale allows clinicians like Dr. Fan Yun Pin to combine Western metabolic surgery with traditional Chinese approaches for endocrine disorders. This integration helps address metabolic syndrome through 28,500+ available technologies while providing the high surgical experience needed for complex cases.
Patient Consensus: Patients note that while early results are impressive, sustaining remission beyond two years requires strict lifestyle changes. Many emphasize that having a local doctor for long-term bloodwork is essential to avoid common post-op nutrient deficiencies.
Postoperative recovery in China for metabolic procedures typically involves a 3 to 7 day hospital stay. Patients often achieve early mobilization within 20 hours post-surgery. Full physical recovery generally occurs within 4 to 8 weeks. Specialized centers like Yanda International Hospital follow JCI-accredited safety protocols.
Bookimed Expert Insight: Yanda International Hospital represents the Class A level III tier, which is the highest clinical ranking in China. This facility handles 2,500,000 patients annually and integrates Western medicine with traditional approaches. Dr. Fan Yun Pin at this center specializes in metabolic syndrome. This high volume and specialized expertise often lead to efficient discharge timelines for international patients.
Patient Consensus: Patients note that mobility starts surprisingly early due to aggressive physiotherapy. Many emphasize using translation apps to communicate effectively with nursing staff during their 10-day total downtime.
Beijing and Shanghai serve as the primary Chinese destinations for high-quality metabolic surgery. These cities host facilities like Yanda International Hospital. Many centers hold JCI accreditation and offer integrative treatments. Specialized departments focus on long-term Type 2 diabetes remission through advanced surgical techniques.
Bookimed Expert Insight: Yanda International Hospital serves over 2,500,000 patients annually and holds the highest Class A level III ranking. This high patient volume often correlates with refined surgical protocols for metabolic syndrome. Patients should prioritize doctors like Dr. Fan Yun Pin who hold national leadership roles in integrative medicine.
Patient Consensus: Patients note that while Beijing and Shanghai offer international-standard facilities, finding English-speaking surgical teams remains a significant challenge. Many advise confirming the availability of post-operative endocrinology support for long-term metabolic monitoring before traveling.